LobbyingSonnet Biotherapeutics lobbying by quarter
Sonnet Biotherapeutics's latest lobbying report covers Q4 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.
Sonnet Biotherapeutics
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $15K | 1 |
| Q1 2023 | $5,000 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medical research and clinical labs2 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Thompson Advisory Group | $20K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/05/14for Q4 2023 | Thompson Advisory Group | Under $5,000 |
| 23/10/23for Q3 2023 | Thompson Advisory Group | Under $5,000 |
| 23/08/15for Q2 2023 | Thompson Advisory Group | Under $5,000 |
| 23/05/16for Q1 2023 | Thompson Advisory Group | $5,000 |
| 23/03/15for Q4 2022 | Thompson Advisory Group | $15K |